Virbac SA
Research Virbac SA (VIRP) on Bullrun: market cap EUR 2.85B, P/E 18.9, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVIRP
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 2.85B
- P/E18.9
- Dividend yield0.4%
- Financial periodFY2024
- RevenueEUR 1.40B
- Revenue growth12.1%
- Net incomeEUR 145.29M
- Free cash flowEUR 123.78M
- Gross margin67.1%
Valuation Snapshot
latest market cap is EUR 2.85B; P/E is 18.9; dividend yield is 0.4%.
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies;
Frequently asked questions
What is Virbac SA's market cap?
Virbac SA's market capitalization is EUR 2.85B.
What is Virbac SA's P/E ratio?
Virbac SA's price-to-earnings (P/E) ratio is 18.9.
Does Virbac SA pay a dividend?
Virbac SA has a dividend yield of 0.4%.
What does Virbac SA do?
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.